Antiviral activity of the non-steroidal anti-inflammatory drug indomethacin against respiratory syncytial virus
Caterina Tramontozzi, Anna Riccio, Simone La Frazia, Valentina Svicher, M. Gabriella Santoro · 2026
Read Antiviral activity of the non-steroidal anti-inflammatory drug indomethacin against respiratory syncytial virus by Caterina Tramontozzi, Anna Riccio, Simone La Frazia, Valentina Svicher, M. Gabriella Santoro (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13227272.txt.
Description
Caterina Tramontozzi and co-authors test whether a common pain drug can also fight respiratory syncytial virus, a widespread cause of lung infection, in a 2026 paper. The virus is the top cause of hospital stays for young children with lung infections. It can be life-threatening for infants under six months, and it also burdens older adults a great deal. A viral surface protein drives entry into airway cells.
Inflammation triggered by the virus is linked with severe disease. Vaccines and antibody products now exist for prevention, but there is still no effective drug cure once infection sets in. The team study the anti-inflammatory drug indomethacin for direct antiviral action. A cheap, known drug that works would fill a clear gap in care for this virus.
Catalog record
| CREATOR | Caterina Tramontozzi, Anna Riccio, Simone La Frazia, Valentina Svicher, M. Gabriella Santoro |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |